Wall Street Analysts Predict a 58.87% Upside in Akero Therapeutics, Inc. (AKRO): Here's What You Should Know

Akero Therapeutics, Inc. (AKRO) closed the last trading session at $26.99, gaining 28.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $42.88 indicates a 58.9% upside potential.The average comprises eight short-term price targets ranging from a low of $33 to a high of $60, with a standard deviation of $10.60. While the lowest estimate indicates an increase of 22.3% from the curre ...